NeonMind Unveils Initial Treatment Offering at Specialty Mental Health Clinic in Mississauga Psychedelics Investing
NeonMind Announces Positive Preclinical Results Demonstrating the Efficacy of Psilocybin in Reducing Weight Gain in Obese Animal Subjects Psychedelics Investing
UNIVERSAL IBOGAINE EXPANDS RESEARCH TEAM WITH JULIE DUMOUCHEL, DIRECTOR OF CLINICAL TRIALS Pharmaceutical Investing
NeonMind Files New Provisional Patent Application Covering Novel Mechanism of Weight Loss Psychedelics Investing
Nirvana Reports Progress with Health Canada Dealer's License Application and Facility Development Psychedelics Investing
Awakn Life Sciences Receives Regulatory Approval for Flagship Clinic in London to Begin Delivering Treatments Psychedelics Investing
SHAREHOLDER ALERT: Weiss Law Reminds CDR, FHN, SYTE, and GDNSF Shareholders About Its Ongoing Investigations Psychedelics Investing
Lobe Sciences Advances Governance and Capital Markets Expertise with Appointment of Mr. Nick Karakochuk to the Board of Directors
